MedPath

MYLAN-IPRATROPIUM SOLUTION

MYLAN-IPRATROPIUM SOLUTION

Discontinued
DIN Number

02239131

Drug Class

Human

Market Date

Dec 4, 1998

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02239131
AIG Number0115643001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BB01 IPRATROPIUM BROMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationInhalation
AHFS Classification12:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

IPRATROPIUM BROMIDEActive
Strength: 250 MCG / ML
Monograph: IPRATROPIUM BROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.